Rafael Holdings (RFL) Research & Development (2018 - 2026)
Rafael Holdings (RFL) reported Research & Development of $7.47 million for fiscal Q4 2026 (quarter ended Jul 31, 2026), compared with $232,000 a year earlier and up 53.9% from the prior quarter.
Powered by 
Analysis
Rafael Holdings (RFL) Research & Development (2018 - 2026) Analysis & Trends
For FY2026 (ended Jul 31, 2026), Rafael Holdings posted Research & Development of $24.33 million, up 89.8% from FY2025.
- Research & Development has a five-year compound annual growth rate of 37.7% (FY2021 to FY2026).
- By fiscal year, Research & Development came in at $12.82 million in FY2025 (+207.5%), $4.17 million in FY2024 (-33.9%), $6.31 million in FY2023 (-27.8%) and $8.74 million in FY2022 (+78.2%).
- Five-year quarterly Research & Development spans a low of $232,000 in fiscal Q4 2025 and a high of $7.48 million in fiscal Q1 2026.
- Year over year, Research & Development gained in six of the last seven quarters, with growth averaging 163.1%.
- The high point for year-over-year Research & Development in five years was fiscal Q1 2026 (growth of 464.4%); the low point was fiscal Q4 2025 (a decline of 85.0%).
- Per Business Quant data, the three fiscal quarters before Q4 2026 came in at $4.85 million (Q3 2026), $4.53 million (Q2 2026) and $7.48 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 3.02 Bn |
| 10 | Rafael Holdings | 55.50 Mn | -80.41 Mn | 218,000.00 | 7.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 7.47 Mn |
| Apr 30, 2026 | 4.85 Mn |
| Jan 31, 2026 | 4.53 Mn |
| Oct 31, 2025 | 7.48 Mn |
| Jul 31, 2025 | 232,000.00 |
| Apr 30, 2025 | 3.00 Mn |
| Jan 31, 2025 | 947,000.00 |
| Oct 31, 2024 | 1.33 Mn |
| Jul 31, 2024 | 1.54 Mn |
| Apr 30, 2024 | 1.53 Mn |
| Jan 31, 2024 | 612,000.00 |
| Oct 31, 2023 | 489,000.00 |
| Jul 31, 2023 | 1.27 Mn |
| Apr 30, 2023 | 740,000.00 |
| Jan 31, 2023 | 2.23 Mn |
| Oct 31, 2022 | 2.08 Mn |
| Jul 31, 2022 | 1.84 Mn |
| Apr 30, 2022 | 1.41 Mn |
| Jan 31, 2022 | 3.34 Mn |
| Oct 31, 2021 | 2.15 Mn |
API Access
Rafael Holdings Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=RFL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "RFL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=RFL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();